The Clinical Research Of Shenfo Weikang Decoction To Treat Chronic Atrophic Gastritis Type Of Deficiency Of Spleen And Qi Stagnation

Chronic atrophic gastritis (CAG) is a common and frequently-occurring, in severe CAG with moderate to severe intestinal metaplasia and severe dysplasia, in close with the incidence of gastric cancer. In recent years, traditional Chinese medicine to the patients in the study of the pathogenesis explore the mechanism of clinical research and treatment are some progress has been made. Under the guidance of the concept of diagnosis and giving of treatment a significant clinical effect, Chinese medicine treats this disease shows a powerful advantage in treatment of this disease using Chinese medicine. This issue in the past 10 years CAG reviewed the progress made on the basis of the study, carried out my tutor, Professor Li Shouchao to experience " Shenfo Weikang decoction " the CAG treatment of clinical research.Objective: To verify the clinical efficacy and safety of " Shenfo Weikang decoction " in the treatment of chronic atrophic gastritis deficiency of deficiency of spleen and qi stagnation with clinical observation; and analysis of the "Buddha Senate Tang Wei Kang" and the results of the treatment mechanism with a view to Chronic atrophic gastritis to provide more effective treatment. Method: In accordance with the randomized, controlled by the principle of the diagnostic criteria, included in the standard screening criteria to exclude the 60 cases of eligible subjects were randomly divided into treatment group 30 cases, 30 cases in the control group. Participation of Chinese medicine in the treatment group to give the Shenfo Weikang decoction, Shui Jianfu, on a 300ml, at morning and evening services. In the control group given oral-dimensional chip-0.8g / times, three days; bismuth pectin 150mg / times, three times on treatment. Clinical symptoms, gastroscopy and observe the effect of blood, urine, fecal conventional, electrocardiogram, liver and kidney, and other security detection Gong, a total of 3 courses, after the end of the treatment of clinical efficacy and safety of the evaluation. Results: The total effective rate was 86.7 percent in the control group total effective rate was 83.3 percent, the group's total effective rate was higher than the control group, but statistically, the two groups showed no significant difference (P> 0 .05); Two groups of patients before and after treatment by the signs and symptoms compared to the treatment group were higher than the total effective rate, the statistical analysis, the difference was significant (P <0.05); two groups of patients after endoscopic treatment, pathology .And the efficacy of anti-HP Statistical analysis than before treatment were significantly different (P <0.05), but the treatment group compared with the control group, no significant difference (P> 0.05); the rate of side effects in the treatment group and control group The rate of adverse reactions by deal with statistical significant difference (P <0.05), higher than safety in the treatment group.Conclusion: Shenfo Wei Kang Decoction is safe and effective medicine to treat Chronic atrophic gastritis deficiency of deficiency of spleen and Qi stagnation.